The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease

Aiello, 2019, Deep brain stimulation of the subthalamic nucleus and the temporal discounting of primary and secondary rewards, J. Neurol., 266, 1113, 10.1007/s00415-019-09240-0 Amami, 2015, Impulse control behaviours in patients with Parkinson’s disease after subthalamic deep brain stimulation: de novo cases and 3-year follow-up, J. Neurol. Neurosurg. Psychiatry, 86, 562, 10.1136/jnnp-2013-307214 Aracil-Bolanos, 2016, Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease, Parkinsonism Relat. Disord., 22, S101, 10.1016/j.parkreldis.2015.08.003 Avanzi, 2006, Prevalence of pathological gambling in patients with Parkinson’s disease, Mov. Disord., 21, 2068, 10.1002/mds.21072 Avila, 2011, Impulsive and compulsive behaviors in Parkinson’s disease: a one-year follow-up study, J. Neurol. Sci., 310, 197, 10.1016/j.jns.2011.05.044 Bancos, 2014, Impulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case-control study, Clin. Endocrinol., 80, 863, 10.1111/cen.12375 Barbosa, 2019, Lower nucleus accumbens alpha-synuclein load and D3 receptor levels in Parkinson’s disease with impulsive compulsive behaviours, Brain, 142, 3580, 10.1093/brain/awz298 Barraud, 2010, Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate, PLoS One, 5, 10.1371/journal.pone.0013306 Barrus, 2016, Dopamine D3 receptors modulate the ability of Win-Paired Cues to increase risky choice in a rat gambling task, J. Neurosci., 36, 785, 10.1523/JNEUROSCI.2225-15.2016 Baunez, 2007, Bilateral high-frequency stimulation of the subthalamic nucleus on attentional performance: transient deleterious effects and enhanced motivation in both intact and parkinsonian rats, Eur. J. Neurosci., 25, 1187, 10.1111/j.1460-9568.2007.05373.x Beckstead, 1988, Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography, J. Comp. Neurol., 268, 131, 10.1002/cne.902680113 Ben-Jonathan, 2001, Dopamine as a prolactin (PRL) inhibitor, Endocr. Rev., 22, 724, 10.1210/edrv.22.6.0451 Berridge, 2007, The debate over dopamine’s role in reward: the case for incentive salience, Psychopharmacology, 191, 391, 10.1007/s00213-006-0578-x Bostwick, 2009, Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease, Mayo Clin. Proc., 84, 310, 10.1016/S0025-6196(11)60538-7 Bouthenet, 1991, Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA, Brain Res., 564, 203, 10.1016/0006-8993(91)91456-B Broen, 2011, Impulse control and related disorders in Parkinson’s disease patients treated with bilateral subthalamic nucleus stimulation: a review, Parkinsonism Relat. Disord., 17, 413, 10.1016/j.parkreldis.2011.02.013 Cagniard, 2006, Dopamine scales performance in the absence of new learning, Neuron, 51, 541, 10.1016/j.neuron.2006.07.026 Callesen, 2014, Impulsive and compulsive behaviors among Danish patients with Parkinson’s disease: prevalence, depression, and personality, Parkinsonism Relat. Disord., 20, 22, 10.1016/j.parkreldis.2013.09.006 Campbell-Meiklejohn, 2011, Serotonin and dopamine play complementary roles in gambling to recover losses, Neuropsychopharmacology, 36, 402, 10.1038/npp.2010.170 Campbell-Meiklejohn, 2008, Knowing when to stop: the brain mechanisms of chasing losses, Biol. Psychiatry, 63, 293, 10.1016/j.biopsych.2007.05.014 Cannas, 2006, Hypersexual behaviour, frotteurism and delusional jealousy in a young parkinsonian patient during dopaminergic therapy with pergolide: a rare case of iatrogenic paraphilia, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 30, 1539, 10.1016/j.pnpbp.2006.05.012 Cardinal, 2006, Neural systems implicated in delayed and probabilistic reinforcement, Neural Netw., 19, 1277, 10.1016/j.neunet.2006.03.004 Casa-Fages, 2012, Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease, J. Neurol. Sci., 312, 191, 10.1016/j.jns.2011.08.014 Cenci, 2015, Rodent models of impulsive-compulsive behaviors in Parkinson’s disease: how far have we reached?, Neurobiol. Dis., 82, 561, 10.1016/j.nbd.2015.08.026 Chernoloz, 2009, Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain, Neuropsychopharmacology, 34, 651, 10.1038/npp.2008.114 Cilia, 2010, Reduced dopamine transporter density in the ventral striatum of patients with Parkinson’s disease and pathological gambling, Neurobiol. Dis., 39, 98, 10.1016/j.nbd.2010.03.013 Cilia, 2011, Impulse control disorders in Parkinson’s disease: seeking a roadmap toward a better understanding, Brain Struct. Funct., 216, 289, 10.1007/s00429-011-0314-0 Claassen, 2017, Mesocorticolimbic hemodynamic response in Parkinson’s disease patients with compulsive behaviors, Mov. Disord., 32, 1574, 10.1002/mds.27047 Clark, 2014, The role of dopamine in risk taking: a specific look at Parkinson’s disease and gambling, Front. Behav. Neurosci., 8, 196, 10.3389/fnbeh.2014.00196 Clemens, 2006, Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective, Neurology, 67, 125, 10.1212/01.wnl.0000223316.53428.c9 Cohen, 2009, Neurocomputational models of basal ganglia function in learning, memory and choice, Behav. Brain Res., 199, 141, 10.1016/j.bbr.2008.09.029 Coldwell, 1999, Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells, Br. J. Pharmacol., 127, 1696, 10.1038/sj.bjp.0702673 Contreras, 1987, Autoradiographic distribution of non-dopaminergic binding sites labeled by 3H-haloperidol in rat brain, Neurosci. Lett., 75, 133, 10.1016/0304-3940(87)90286-2 Dalley, 2011, Impulsivity, compulsivity, and top-down cognitive control, Neuron, 69, 680, 10.1016/j.neuron.2011.01.020 Dalley, 2008, Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry, Pharmacol. Biochem. Behav., 90, 250, 10.1016/j.pbb.2007.12.021 Dang, 2011, The emergence of devastating impulse control disorders during dopamine agonist therapy of the restless legs syndrome, Clin. Neuropharmacol., 34, 66, 10.1097/WNF.0b013e31820d6699 Dardou, 2014, Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats, Front. Neurosci., 8, 437 De Micco, 2018, Impulse control behaviors in parkinson’s disease: drugs or disease? Contribution from imaging studies, Front. Neurol., 9, 893, 10.3389/fneur.2018.00893 Deutschlander, 2016, Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson’s disease patients, Neuroimage Clin., 12, 41, 10.1016/j.nicl.2016.06.007 Diaz, 1995, Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain, Neuroscience, 65, 731, 10.1016/0306-4522(94)00527-C Dodd, 2005, Pathological gambling caused by drugs used to treat Parkinson disease, Arch. Neurol., 62, 1377, 10.1001/archneur.62.9.noc50009 Dogansen, 2019, Dopamine agonist-induced impulse control disorders in patients with prolactinoma: A cross-sectional multicenter study, J. Clin. Endocrinol. Metab., 104, 2527, 10.1210/jc.2018-02202 Dooley, 1998, Pramipexole. A review of its use in the management of early and advanced Parkinson’s disease, Drugs Aging, 12, 495, 10.2165/00002512-199812060-00007 Drapier, 2006, Pathological gambling secondary to dopaminergic therapy in Parkinson’s disease, Psychiatry Res., 144, 241, 10.1016/j.psychres.2006.04.017 Drijgers, 2012, The role of the dopaminergic system in mood, motivation and cognition in Parkinson’s disease: a double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate, J. Neurol. Sci., 320, 121, 10.1016/j.jns.2012.07.015 Driver-Dunckley, 2003, Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease, Neurology, 61, 422, 10.1212/01.WNL.0000076478.45005.EC Driver-Dunckley, 2007, Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome, Clin. Neuropharmacol., 30, 249, 10.1097/wnf.0b013e31804c780e van Eimeren, 2009, Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson’s disease?, Neuropsychopharmacology, 34, 2758, 10.1038/npp.2009.124 van Eimeren, 2010, Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD, Neurology, 75, 1711, 10.1212/WNL.0b013e3181fc27fa Eisinger, 2019, Medications, deep brain stimulation, and other factors influencing impulse control disorders in Parkinson’s disease, Front. Neurol., 10, 86, 10.3389/fneur.2019.00086 El Otmani, 2019, Impulse control disorders in Parkinson disease: a cross-sectional study in Morocco, Rev. Neurol. (Paris), 175, 233, 10.1016/j.neurol.2018.07.009 Ernst, 1965, Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS, Psychopharmacologia, 7, 391, 10.1007/BF00402361 Etminan, 2003, Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson’s disease: a meta-analysis, Drug Saf., 26, 439, 10.2165/00002018-200326060-00005 Eusebio, 2013, Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry, 84, 868, 10.1136/jnnp-2012-302387 Evans, 2004, Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome, Mov. Disord., 19, 397, 10.1002/mds.20045 Evans, 2019, Scales to assess impulsive and compulsive behaviors in Parkinson’s disease: critique and recommendations, Mov. Disord., 34, 791, 10.1002/mds.27689 Evans, 2006, Compulsive drug use linked to sensitized ventral striatal dopamine transmission, Ann. Neurol., 59, 852, 10.1002/ana.20822 Fasano, 2010, Insights into pathophysiology of punding reveal possible treatment strategies, Mol. Psychiatry, 15, 560, 10.1038/mp.2009.95 Fekete, 1970, On the dopaminergic nature of the gnawing compulsion induced by apomorphine in mice, J. Pharm. Pharmacol., 22, 377, 10.1111/j.2042-7158.1970.tb08542.x Fineberg, 2010, Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review, Neuropsychopharmacology, 35, 591, 10.1038/npp.2009.185 Floresco, 2008, Dopaminergic and glutamatergic regulation of effort- and delay-based decision making, Neuropsychopharmacology, 33, 1966, 10.1038/sj.npp.1301565 Frank, 2007, Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism, Science, 318, 1309, 10.1126/science.1146157 Fujimoto, 2019, Signaling incentive and drive in the primate ventral pallidum for motivational control of goal-directed action, J. Neurosci., 39, 1793, 10.1523/JNEUROSCI.2399-18.2018 Gallagher, 2007, Pathological gambling in Parkinson’s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series, Mov. Disord., 22, 1757, 10.1002/mds.21611 Garcia-Ruiz, 2014, Impulse control disorder in patients with Parkinson’s disease under dopamine agonist therapy: a multicentre study, J. Neurol. Neurosurg. Psychiatry, 85, 840, 10.1136/jnnp-2013-306787 Gatto, 2019, Impulse control disorders in parkinson’s disease. A brief and comprehensive review, Front. Neurol., 10, 351, 10.3389/fneur.2019.00351 Graff-Guerrero, 2010, Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925, Int. J. Neuropsychopharmacol., 13, 273, 10.1017/S1461145709990642 Graff-Guerrero, 2008, Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans, Hum. Brain Mapp., 29, 400, 10.1002/hbm.20392 Grall-Bronnec, 2018, Dopamine agonists and impulse control disorders: a complex association, Drug Saf., 41, 19, 10.1007/s40264-017-0590-6 Grant, 2010, Introduction to behavioral addictions, Am. J. Drug Alcohol Abuse, 36, 233, 10.3109/00952990.2010.491884 Grosset, 2006, Problematic gambling on dopamine agonists: Not such a rarity, Mov. Disord., 21, 2206, 10.1002/mds.21110 Gschwandtner, 2001, Pathologic gambling in patients with Parkinson’s disease, Clin. Neuropharmacol., 24, 170, 10.1097/00002826-200105000-00009 Hamidovic, 2009, Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants, Exp. Clin. Psychopharmacol., 17, 374, 10.1037/a0017840 Hamidovic, 2008, Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers, J. Clin. Psychopharmacol., 28, 45, 10.1097/jcp.0b013e3181602fab Hassan, 2011, Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies, Parkinsonism Relat. Disord., 17, 260, 10.1016/j.parkreldis.2011.01.009 Hauser, 2000, Pramipexole-induced somnolence and episodes of daytime sleep, Mov. Disord., 15, 658, 10.1002/1531-8257(200007)15:4<658::AID-MDS1009>3.0.CO;2-N Heidenreich, 1995, Partial and full dopamine D1 agonists produce comparable increases in ventral pallidal neuronal activity: Contribution of endogenous dopamine, J. Pharmacol. Exp. Ther., 273, 516 Holtz, 2016, Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson’s disease, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 70, 77, 10.1016/j.pnpbp.2016.05.004 Ishibashi, 2011, Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457, PLoS One, 6, 10.1371/journal.pone.0017723 Jimenez-Urbieta, 2019, Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson’s disease, Neurobiol. Aging, 75, 126, 10.1016/j.neurobiolaging.2018.11.021 Johnson, 2011, Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats, Psychopharmacology, 231, 11, 10.1007/s00213-010-2006-5 Joutsa, 2015, Dopaminergic function and intertemporal choice, Transl. Psychiatry, 5 Jung, 2018, Amygdala Functional and Structural Connectivity Predicts Individual Risk Tolerance, Neuron, 98, 394, 10.1016/j.neuron.2018.03.019 Kanovsky, 2002, Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson’s disease, J. Neurol., 249, 112, 10.1007/PL00007840 Kasemsuk, 2017, Management of impulse control disorders with deep brain stimulation: A double-edged sword, J. Neurol. Sci., 374, 63, 10.1016/j.jns.2017.01.019 Kim, 2018, A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson’s disease, Parkinsonism Relat. Disord., 56, 3, 10.1016/j.parkreldis.2018.07.010 Kish, 1988, Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson’s disease. Pathophysiologic and clinical implications, N. Engl. J. Med., 318, 876, 10.1056/NEJM198804073181402 Klos, 2005, Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson’s disease and multiple system atrophy, Parkinsonism Relat. Disord., 11, 381, 10.1016/j.parkreldis.2005.06.005 Kon, 2018, The factors associated with impulse control behaviors in Parkinson’s disease: A 2-year longitudinal retrospective cohort study, Brain Behav., 8, 10.1002/brb3.1036 Kraemmer, 2016, Clinical-genetic model predicts incident impulse control disorders in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry, 87, 1106, 10.1136/jnnp-2015-312848 Larner, 2006, Medical hazards of the internet: gambling in Parkinson’s disease, Mov. Disord., 21, 1789, 10.1002/mds.21057 Lee, 2009, Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson’s disease, Mov. Disord., 24, 1803, 10.1002/mds.22678 Lee, 2014, Extrastriatal dopaminergic changes in Parkinson’s disease patients with impulse control disorders, J. Neurol. Neurosurg. Psychiatry, 85, 23, 10.1136/jnnp-2013-305549 Leentjens, 2009, The effect of pramipexole on mood and motivational symptoms in Parkinson’s disease: a meta-analysis of placebo-controlled studies, Clin. Ther., 31, 89, 10.1016/j.clinthera.2009.01.012 Levesque, 1992, Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin, Proc. Natl. Acad. Sci. U. S. A., 89, 8155, 10.1073/pnas.89.17.8155 Lhommee, 2012, Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours, Brain, 135, 1463, 10.1093/brain/aws078 Lipford, 2012, Long-term use of pramipexole in the management of restless legs syndrome, Sleep Med., 13, 1280, 10.1016/j.sleep.2012.08.004 Loane, 2015, Psychogenic and neural visual-cue response in PD dopamine dysregulation syndrome, Parkinsonism Relat. Disord., 21, 1336, 10.1016/j.parkreldis.2015.09.042 Madden, 2010, Effects of pramipexole on impulsive choice in male wistar rats, Exp. Clin. Psychopharmacol., 18, 267, 10.1037/a0019244 Malapani, 1998, Coupled temporal memories in Parkinson’s disease: a dopamine-related dysfunction, J. Cogn. Neurosci., 10, 316, 10.1162/089892998562762 Mallet, 2008, Subthalamic nucleus stimulation in severe obsessive-compulsive disorder, N. Engl. J. Med., 359, 2121, 10.1056/NEJMoa0708514 Mamikonyan, 2008, Long-term follow-up of impulse control disorders in Parkinson’s disease, Mov. Disord., 23, 75, 10.1002/mds.21770 Mandali, 2016, Electrode position and current amplitude modulate impulsivity after subthalamic stimulation in Parkinsons disease-a computational study, Front. Physiol., 7, 585, 10.3389/fphys.2016.00585 Mansour, 1990, Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis, J. Neurosci., 10, 2587, 10.1523/JNEUROSCI.10-08-02587.1990 Martini, 2018, Dopaminergic neurotransmission in patients with Parkinson’s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies, Front. Neurol., 9, 1018, 10.3389/fneur.2018.01018 Martinkova, 2011, Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas, Clin. Neuropharmacol., 34, 179, 10.1097/WNF.0b013e3182281b2f Maslowski, 1991, Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons, Eur. J. Pharmacol., 200, 103, 10.1016/0014-2999(91)90672-D Maslowski-Cobuzzi, 1994, Activation of dopaminergic neurons modulates ventral pallidal responses evoked by amygdala stimulation, Neuroscience, 62, 1103, 10.1016/0306-4522(94)90347-6 Merola, 2017, Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease, J. Neurol., 264, 40, 10.1007/s00415-016-8314-x Mierau, 1995, Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors, Eur. J. Pharmacol., 290, 29, 10.1016/0922-4106(95)90013-6 Mitrovic, 2002, Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum, Eur. J. Neurosci., 15, 257, 10.1046/j.0953-816x.2001.01860.x Miwa, 2005, Increased writing activity in Parkinson’s disease: a punding-like behavior?, Parkinsonism Relat. Disord., 11, 323, 10.1016/j.parkreldis.2005.02.009 Molina, 2000, Pathologic gambling in Parkinson’s disease: a behavioral manifestation of pharmacologic treatment?, Mov. Disord., 15, 869, 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I Napier, 1992, Contribution of the amygdala and nucleus accumbens to ventral pallidal responses to dopamine agonists, Synapse, 10, 110, 10.1002/syn.890100205 Ondo, 2014, Restless legs syndrome: pathophysiology and treatment, Curr. Treat. Options Neurol., 16, 317, 10.1007/s11940-014-0317-2 Ondo, 2008, Predictors of impulsivity and reward seeking behavior with dopamine agonists, Parkinsonism Relat. Disord., 14, 28, 10.1016/j.parkreldis.2007.05.006 Orru, 2020, The averse effects of pramipexole on probability discounting are not reversed by acute D2 or D3 receptor antagonism, Eur. Neuropsychopharmacol., 32, 104, 10.1016/j.euroneuro.2020.01.005 O’Suilleabhain, 2002, Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease, Arch. Neurol., 59, 986, 10.1001/archneur.59.6.986 O’Sullivan, 2011, Cue-induced striatal dopamine release in Parkinson’s disease-associated impulsive-compulsive behaviours, Brain, 134, 969, 10.1093/brain/awr003 Ottenheimer, 2018, Ventral pallidum encodes relative reward value earlier and more robustly than nucleus accumbens, Nat. Commun., 9, 4350, 10.1038/s41467-018-06849-z Pastor, 1992, Time estimation and reproduction is abnormal in Parkinson’s disease, Brain, 115, 211, 10.1093/brain/115.1.211 Paulus, 2007, Pathophysiological concepts of restless legs syndrome, Mov. Disord., 22, 1451, 10.1002/mds.21533 Payer, 2015, [(1)(1)C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson’s disease with impulse control disorders, Mov. Disord., 30, 160, 10.1002/mds.26135 Perez-Lloret, 2012, Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease, Clin. Neuropharmacol., 35, 261, 10.1097/WNF.0b013e31826e6e6d Pes, 2017, Pramipexole enhances disadvantageous decision-making: lack of relation to changes in phasic dopamine release, Neuropharmacology, 114, 77, 10.1016/j.neuropharm.2016.11.014 Petersen, 2018, Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson’s disease, Hum. Brain Mapp., 39, 509, 10.1002/hbm.23860 Petry, 2005, Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions, J. Clin. Psychiatry, 66, 564, 10.4088/JCP.v66n0504 Pezzella, 2005, Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson’s disease, Mov. Disord., 20, 77, 10.1002/mds.20288 Politis, 2017, Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson’s patients, Neuroimage Clin., 16, 455, 10.1016/j.nicl.2017.08.013 Pontone, 2006, Clinical features associated with impulse control disorders in Parkinson disease, Neurology, 67, 1258, 10.1212/01.wnl.0000238401.76928.45 Postuma, 2015, MDS clinical diagnostic criteria for Parkinson’s disease, Mov. Disord., 30, 1591, 10.1002/mds.26424 Pourcher, 2010, Compulsive habits in restless legs syndrome patients under dopaminergic treatment, J. Neurol. Sci., 290, 52, 10.1016/j.jns.2009.11.010 Ramdave, 2019, Unmasking neurobiological commonalities between addictive disorders and impulse control disorders in Parkinson’s disease, Brain Imaging Behav., 10.1007/s11682-019-00041-7 Ramirez Gomez, 2017, A multicenter comparative study of impulse control disorder in latin american patients with Parkinson disease, Clin. Neuropharmacol., 40, 51, 10.1097/WNF.0000000000000202 Rao, 2010, Decreased ventral striatal activity with impulse control disorders in Parkinson’s disease, Mov. Disord., 25, 1660, 10.1002/mds.23147 Ray, 2012, Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson’s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study, Neurobiol. Dis., 48, 519, 10.1016/j.nbd.2012.06.021 Riba, 2008, Dopamine agonist increases risk taking but blunts reward-related brain activity, PLoS One, 3, 10.1371/journal.pone.0002479 Richfield, 1989, Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system, Neuroscience, 30, 767, 10.1016/0306-4522(89)90168-1 Riddle, 2012, Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson’s disease and controls, Behav. Brain Res., 233, 15, 10.1016/j.bbr.2012.04.027 Ridray, 1998, Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions, Eur. J. Neurosci., 10, 1676, 10.1046/j.1460-9568.1998.00173.x Rodriguez-Violante, 2014, Impulse control and related disorders in Mexican Parkinson’s disease patients, Parkinsonism Relat. Disord., 20, 907, 10.1016/j.parkreldis.2014.05.014 Rogers, 2011, Deep brain stimulation of the subthalamic nucleus transiently enhances loss-chasing behaviour in patients with Parkinson’s disease, Exp. Neurol., 231, 181, 10.1016/j.expneurol.2011.06.007 Rokosik, 2012, Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson’s disease and controls, Neuropsychopharmacology, 37, 1397, 10.1038/npp.2011.325 Root, 2015, The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors, Prog. Neurobiol., 130, 29, 10.1016/j.pneurobio.2015.03.005 Rossi, 2017, Measures of impulsivity in Parkinson’s disease decrease after DBS in the setting of stable dopamine therapy, Parkinsonism Relat. Disord., 44, 13, 10.1016/j.parkreldis.2017.08.006 Rossi, 2015, The subthalamic nucleus, limbic function, and impulse control, Neuropsychol. Rev., 25, 398, 10.1007/s11065-015-9306-9 Saga, 2017, Ventral pallidum encodes contextual information and controls aversive behaviors, Cereb. Cortex, 27, 2528 Salamone, 2007, Functions of mesolimbic dopamine: changing concepts and shifting paradigms, Psychopharmacology, 191, 389, 10.1007/s00213-006-0623-9 Samuels, 2006, Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers, Psychopharmacology, 187, 498, 10.1007/s00213-006-0443-y Samuels, 2006, Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers, J. Psychopharmacol., 20, 756, 10.1177/0269881106060770 Samuels, 2007, Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers, Br. J. Clin. Pharmacol., 64, 591, 10.1111/j.1365-2125.2007.02938.x Schultz, 2016, Dopamine reward prediction-error signalling: a two-component response, Nat. Rev. Neurosci., 17, 183, 10.1038/nrn.2015.26 Seedat, 2000, Pathological gambling behaviour: emergence secondary to treatment of Parkinson’s disease with dopaminergic agents, Depress. Anxiety, 11, 185, 10.1002/1520-6394(2000)11:4<185::AID-DA8>3.0.CO;2-H Seinstra, 2016, No effect of subthalamic deep brain stimulation on intertemporal decision-making in Parkinson patients, eNeuro, 3, 10.1523/ENEURO.0019-16.2016 Shaffer, 1999, Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis, Am. J. Public Health, 89, 1369, 10.2105/AJPH.89.9.1369 Shaffer, 2004, Toward a syndrome model of addiction: multiple expressions, common etiology, Harv. Rev. Psychiatry, 12, 367, 10.1080/10673220490905705 Silber, 2003, Pramipexole in the management of restless legs syndrome: an extended study, Sleep, 26, 819, 10.1093/sleep/26.7.819 Silveira-Moriyama, 2006, Punding and dyskinesias, Mov. Disord., 21, 2214, 10.1002/mds.21118 Siri, 2015, Long-term cognitive follow-up of Parkinson’s disease patients with impulse control disorders, Mov. Disord., 30, 696, 10.1002/mds.26160 Smith, 2016, Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease, J. Neurol. Neurosurg. Psychiatry, 87, 864, 10.1136/jnnp-2015-311827 Sohtaoglu, 2010, Long term follow-up of Parkinson’s disease patients with impulse control disorders, Parkinsonism Relat. Disord., 16, 334, 10.1016/j.parkreldis.2010.02.006 Sokoloff, 1992, Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: Comparison with D2 receptor, Eur. J. Pharmacol. Mol. Pharmacol., 225, 331, 10.1016/0922-4106(92)90107-7 Sokoloff, 2017, The dopamine D3 receptor, a quarter century later, European Journal of Neuroscience, 45, 2, 10.1111/ejn.13390 St Onge, 2012, Dynamic fluctuations in dopamine efflux in the prefrontal cortex and nucleus accumbens during risk-based decision making, J. Neurosci., 32, 16880, 10.1523/JNEUROSCI.3807-12.2012 Stark, 2018, Nigrostriatal and mesolimbic D2/3 receptor expression in Parkinson’s disease patients with compulsive reward-driven behaviors, J. Neurosci., 38, 3230, 10.1523/JNEUROSCI.3082-17.2018 Steeves, 2009, Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study, Brain, 132, 1376, 10.1093/brain/awp054 Stopper, 2015, Dopaminergic circuitry and risk/reward decision making: implications for schizophrenia, Schizophr. Bull., 41, 9, 10.1093/schbul/sbu165 Tedford, 2014, A new approach to assess gambling-like behavior in laboratory rats: using intracranial self-stimulation as a positive reinforcer, Front. Behav. Neurosci., 8, 215, 10.3389/fnbeh.2014.00215 Tedford, 2015, Dopaminergic lesions of the dorsolateral striatum in rats increase delay discounting in an impulsive choice task, PLoS One, 10, 10.1371/journal.pone.0122063 Torregrossa, 2008, Impulsivity, compulsivity, and habit: the role of orbitofrontal cortex revisited, Biol. Psychiatry, 63, 253, 10.1016/j.biopsych.2007.11.014 Tremblay, 2017, Chronic D2/3 agonist ropinirole treatment increases preference for uncertainty in rats regardless of baseline choice patterns, Eur. J. Neurosci., 45, 159, 10.1111/ejn.13332 Turner, 2008, Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson’s Disease: implications for limbic system and basal ganglia interactions, Brain Struct. Funct., 213, 197, 10.1007/s00429-008-0190-4 Turner, 2001, Regulation of limbic information outflow by the subthalamic nucleus: excitatory amino acid projections to the ventral pallidum, J. Neurosci., 21, 2820, 10.1523/JNEUROSCI.21-08-02820.2001 Turner, 2002, Alterations in responses of ventral pallidal neurons to excitatory amino acids after long-term dopamine depletion, J. Pharmacol. Exp. Ther., 301, 371, 10.1124/jpet.301.1.371 Tziortzi, 2011, Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy, Neuroimage, 54, 264, 10.1016/j.neuroimage.2010.06.044 Vachez, 2020, Subthalamic nucleus stimulation impairs motivation: Implication for apathy in Parkinson’s disease, Mov. Disord., 10.1002/mds.27953 Van Rossum, 1970, Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors, Mod. Probl. Pharmacopsychiatry, 5, 65 Vela, 2016, The high prevalence of impulse control behaviors in patients with early-onset Parkinson’s disease: A cross-sectional multicenter study, J. Neurol. Sci., 368, 150, 10.1016/j.jns.2016.07.003 Voon, 2009, Chronic dopaminergic stimulation in Parkinson’s disease: from dyskinesias to impulse control disorders, Lancet Neurol., 8, 1140, 10.1016/S1474-4422(09)70287-X Voon, 2011, Dopamine agonists and risk: impulse control disorders in Parkinson’s disease, Brain, 134, 1438, 10.1093/brain/awr080 Voon, 2006, Prospective prevalence of pathologic gambling and medication association in Parkinson disease, Neurology, 66, 1750, 10.1212/01.wnl.0000218206.20920.4d Voon, 2010, Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors, Neuron, 65, 135, 10.1016/j.neuron.2009.12.027 Voon, 2007, Medication-related impulse control and repetitive behaviors in Parkinson’s disease, Curr. Opin. Neurol., 20, 484, 10.1097/WCO.0b013e32826fbc8f Voon, 2011, Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome, BMC Neurol., 11, 117, 10.1186/1471-2377-11-117 Voon, 2011, Impulse control disorders in Parkinson disease: a multicenter case-control study, Ann. Neurol., 69, 986, 10.1002/ana.22356 Vriend, 2014, Reduced dopamine transporter binding predates impulse control disorders in Parkinson’s disease, Mov. Disord., 29, 904, 10.1002/mds.25886 Wagenbreth, 2015, Deep brain stimulation of the subthalamic nucleus modulates reward processing and action selection in Parkinson patients, J. Neurol., 262, 1541, 10.1007/s00415-015-7749-9 Weintraub, 2009, Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease, Mov. Disord., 24, 1461, 10.1002/mds.22571 Weintraub, 2010, Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients, Arch. Neurol., 67, 589, 10.1001/archneurol.2010.65 Weintraub, 2019, The neuropsychiatry of Parkinson disease: a perfect storm, Am. J. Geriatr. Psychiatry, 27, 998, 10.1016/j.jagp.2019.03.002 Weintraub, 2012, Questionnaire for impulsive-compulsive disorders in Parkinson’s Disease-Rating Scale, Mov. Disord., 27, 242, 10.1002/mds.24023 Weintraub, 2013, Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study, Neurology, 80, 176, 10.1212/WNL.0b013e31827b915c Weintraub, 2006, Association of dopamine agonist use with impulse control disorders in Parkinson disease, Arch. Neurol., 63, 969, 10.1001/archneur.63.7.969 Wermuth, 1998, A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson’s disease, Eur. J. Neurol., 5, 235, 10.1046/j.1468-1331.1998.530235.x Wong, 2007, Internet gambling and other pathological gambling in Parkinson’s disease: a case series, Mov. Disord., 22, 591, 10.1002/mds.21334 Wu, 2015, Single versus multiple impulse control disorders in Parkinson’s disease: an (1)(1)C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release, J. Neurol., 262, 1504, 10.1007/s00415-015-7722-7 Wulff, 2019, Ventral pallidal modulation of aversion processing, Brain Res., 1713, 62, 10.1016/j.brainres.2018.10.010 Zeeb, 2010, Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues, Psychopharmacology, 211, 87, 10.1007/s00213-010-1871-2